We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Instrumentarium to Divest Cardiology Monitoring Unit

By HospiMedica staff writers
Posted on 13 Jan 2003
Print article
An agreement to sell the cardiology business subsidiary of its Spacelabs Medical division for US$ 24 million to Quinton Cardiology Systems, Inc. (Bothell, WA, USA) has been announced by Instrumentarium (Helsinki, Finland). The cardiology subsidiary is Burdick, Inc. (Deerfield, WI, USA).

Burdick is a supplier of electrocardiogram (ECG) cardiographs, Holter monitors, stress testing systems, and cardiology information systems. The company had net sales of about $38 million in 2001. Quinton is a provider of cardiac stress testing systems, cardiac rehabilitation equipment, Holter monitoring devices, and ECG management systems. Quinton's 2001 sales were $42.9 million.

As part of the transaction, Quinton and Spacelabs Medical have entered into a cooperative sales and marketing agreement for certain products as well as an agreement to cross-license certain intellectual property related to ECG technologies and systems. Instrumentarium acquired Spacelabs Medical in July 2002, in a move to strengthen its presence in the critical care patient-monitoring market.





Related Links:
Instrumentarium
Quinton
SpaceLabs
Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Treadmill Test (TMT) System
GEMINI
New
Bioengineered Collagen Implant
Tapestry Biointegrative Implant

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.